Alimera Sciences to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022, and Provide Corporate Update
Conference Call to be held Thursday, February 24, 2022, at 9:00am Eastern Time ATLANTA, Feb….
Year: 2022
Arvinas PROTAC® Protein Degrader Bavdegalutamide (ARV-110) Continues to Demonstrate Clinical Benefit in Men with Metastatic Castration-Resistant Prostate Cancer
– Bavdegalutamide treatment demonstrated robust activity in molecularly defined tumors (androgen receptor T878X/H875Y), with a…
Catalyst Biosciences Engages Perella Weinberg Partners to Assist the Company in Exploring Strategic Alternatives
SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
Pharmazz Inc. Announces Completion of Enrollment of Phase III Clinical Trial Evaluating Sovateltide as a Treatment for Acute Cerebral Ischemic Stroke
Sovateltide is an endothelin B receptor agonist that increases blood flow, shows anti-apoptotic activity, protects…
Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Neopharm for its Lead Asset, QRX003, for Netherton Syndrome
Neopharm Gains Exclusive Rights to Commercialize QRX003 in Israel Sixth Distribution Partnership Established Since Quoin’s…
Longeveron Adds Seasoned Biotech Executive Todd Girolamo to Its Board of Directors
Girolamo brings legal, finance and M&A experience to cell therapy company MIAMI, Feb. 17, 2022…
Science 37®’s Community Provider Network Grows Sixfold, Reaching Nearly 28 Million Patients
Since January 2021, Science 37’s community provider network has added nearly 35,000 physician-providers to enable…
iSpecimen Reports Full Year 2021 Financial Results
Record FY 2021 Revenue of $11.1 Million, Surpassing FY 2020 Revenue of $8.2 Million by…
Intellia Therapeutics Announces Two Upcoming Investor Events in February 2022
Fourth quarter and full-year 2021 financial results – February 24, at 8:00 a.m. ET Updated…
Arbutus to Report Fourth Quarter and Year End 2021 Financial Results and Provide Corporate Update
WARMINSTER, Pa., Feb. 17, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage…
Kura Oncology to Report Fourth Quarter and Full Year 2021 Financial Results
SAN DIEGO, Feb. 17, 2022 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
Otonomy to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update
SAN DIEGO, Feb. 17, 2022 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated…
Avalo Therapeutics Announces Leadership Transition
Promotes Dr. Garry Neil to Chief Executive OfficerPromotes Chris Sullivan to Chief Financial Officer WAYNE,…
XOMA to Present at Aegis Capital Corp Investor Conference
EMERYVILLE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty…
Repligen Reports Fourth Quarter and Full Year 2021 Financial Results
— Record revenue of $186.5 million for the quarter, and year-over-year growth of 72% —…
Verizon protects over 80 million customers from more than 20 billion unwanted calls
Verizon adds new features to Call Filter app and enhanced experience for Fios Digital Voice…
New AI-driven Mobile Voice Analytics Product from Guavus Helps Operators Meet Customers’ Great Expectations for 5G
Guavus Ops-IQ Mobile Voice Analytics New Guavus AI-driven mobile analytics product helps operators meet customers’…
NordPass announces partnership with Cowbell Cyber
The partnership will aim to help cyber insurance policyholders boost their cyber hygiene LONDON, Feb….
Subskribe Launches From Stealth to Power ‘Post-Subscription SaaS’
8VC Leads Series A, Slow Ventures Leads Seed for $18.4M Total Investment in Transformational Quote-to-Revenue…
Bridgeline Announces New Product Suite For Multi-Location Businesses
WOBURN, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a cloud-based…